These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 15695156)

  • 1. The mGlu5 receptor antagonists MPEP and MTEP attenuate behavioral signs of morphine withdrawal and morphine-withdrawal-induced activation of locus coeruleus neurons in rats.
    Rasmussen K; Martin H; Berger JE; Seager MA
    Neuropharmacology; 2005 Feb; 48(2):173-80. PubMed ID: 15695156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of metabotropic glutamate 5 receptor antagonists on morphine efficacy and tolerance in rats with neuropathic pain.
    Zhou Q; Wang J; Zhang X; Zeng L; Wang L; Jiang W
    Eur J Pharmacol; 2013 Oct; 718(1-3):17-23. PubMed ID: 24041921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [3H]Methoxymethyl-3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine binding to metabotropic glutamate receptor subtype 5 in rodent brain: in vitro and in vivo characterization.
    Anderson JJ; Rao SP; Rowe B; Giracello DR; Holtz G; Chapman DF; Tehrani L; Bradbury MJ; Cosford ND; Varney MA
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1044-51. PubMed ID: 12438526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective activity of the mGluR5 antagonists MPEP and MTEP against acute excitotoxicity differs and does not reflect actions at mGluR5 receptors.
    Lea PM; Movsesyan VA; Faden AI
    Br J Pharmacol; 2005 Jun; 145(4):527-34. PubMed ID: 15821750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The behavioral profile of the potent and selective mGlu5 receptor antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine (MTEP) in rodent models of anxiety.
    Busse CS; Brodkin J; Tattersall D; Anderson JJ; Warren N; Tehrani L; Bristow LJ; Varney MA; Cosford ND
    Neuropsychopharmacology; 2004 Nov; 29(11):1971-9. PubMed ID: 15305166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective mGlu5 receptor antagonist MTEP attenuates naloxone-induced morphine withdrawal symptoms.
    Pałucha A; Brański P; Pilc A
    Pol J Pharmacol; 2004; 56(6):863-6. PubMed ID: 15662102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of various glutamate receptors antagonists on anxiety-like effect of ethanol withdrawal in a plus-maze test in rats.
    Kotlinska J; Bochenski M
    Eur J Pharmacol; 2008 Nov; 598(1-3):57-63. PubMed ID: 18838071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The selective mGlu2/3 receptor antagonist LY341495 exacerbates behavioral signs of morphine withdrawal and morphine-withdrawal-induced activation of locus coeruleus neurons.
    Rasmussen K; Hsu MA; Vandergriff J
    Neuropharmacology; 2004 Apr; 46(5):620-8. PubMed ID: 14996539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactive effects of the mGlu5 receptor antagonist MPEP and the mGlu2/3 receptor antagonist LY341495 on nicotine self-administration and reward deficits associated with nicotine withdrawal in rats.
    Liechti ME; Markou A
    Eur J Pharmacol; 2007 Jan; 554(2-3):164-74. PubMed ID: 17113075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the role of metabotropic glutamate receptor 5 in multiple nociceptive modalities.
    Zhu CZ; Wilson SG; Mikusa JP; Wismer CT; Gauvin DM; Lynch JJ; Wade CL; Decker MW; Honore P
    Eur J Pharmacol; 2004 Dec; 506(2):107-18. PubMed ID: 15588730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analgesic effects of mGlu1 and mGlu5 receptor antagonists in the rat formalin test.
    Sevostianova N; Danysz W
    Neuropharmacology; 2006 Sep; 51(3):623-30. PubMed ID: 16793067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the locus coeruleus and N-methyl-D-aspartic acid (NMDA) and AMPA receptors in opiate withdrawal.
    Rasmussen K
    Neuropsychopharmacology; 1995 Dec; 13(4):295-300. PubMed ID: 8747753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of the mGlu5 receptor decreases basal and stress-induced cortical norepinephrine in rodents.
    Page ME; Szeliga P; Gasparini F; Cryan JF
    Psychopharmacology (Berl); 2005 Apr; 179(1):240-6. PubMed ID: 15717212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the effects of mGluR1 and mGluR5 antagonists on the expression of behavioral sensitization to the locomotor effect of morphine and the morphine withdrawal jumping in mice.
    Kotlinska J; Bochenski M
    Eur J Pharmacol; 2007 Mar; 558(1-3):113-8. PubMed ID: 17222405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional profiling of the rat frontal cortex following administration of the mGlu5 receptor antagonists MPEP and MTEP.
    Gass JT; Olive MF
    Eur J Pharmacol; 2008 Apr; 584(2-3):253-62. PubMed ID: 18346726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NMDA receptor antagonists suppress behaviors but not norepinephrine turnover or locus coeruleus unit activity induced by opiate withdrawal.
    Rasmussen K; Fuller RW; Stockton ME; Perry KW; Swinford RM; Ornstein PL
    Eur J Pharmacol; 1991 May; 197(1):9-16. PubMed ID: 1832640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of ionotropic and metabotropic glutamate receptor ligands on anxiety-like effect of amphetamine withdrawal in rats.
    Koltunowska D; Gibula-Bruzda E; Kotlinska JH
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():242-9. PubMed ID: 23623810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The selective mGlu2/3 receptor agonist LY354740 attenuates morphine-withdrawal-induced activation of locus coeruleus neurons and behavioral signs of morphine withdrawal.
    Vandergriff J; Rasmussen K
    Neuropharmacology; 1999 Feb; 38(2):217-22. PubMed ID: 10218862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The metabotropic glutamate 5 receptor antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]-pyridine reduces ethanol self-administration in multiple strains of alcohol-preferring rats and regulates olfactory glutamatergic systems.
    Cowen MS; Djouma E; Lawrence AJ
    J Pharmacol Exp Ther; 2005 Nov; 315(2):590-600. PubMed ID: 16014750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antinociceptive and anxiolytic-like effects of the metabotropic glutamate receptor 5 (mGluR5) antagonists, MPEP and MTEP, and the mGluR1 antagonist, LY456236, in rodents: a comparison of efficacy and side-effect profiles.
    Varty GB; Grilli M; Forlani A; Fredduzzi S; Grzelak ME; Guthrie DH; Hodgson RA; Lu SX; Nicolussi E; Pond AJ; Parker EM; Hunter JC; Higgins GA; Reggiani A; Bertorelli R
    Psychopharmacology (Berl); 2005 Apr; 179(1):207-17. PubMed ID: 15682298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.